Literature DB >> 17610274

Generation of a conditional Ppap2b/Lpp3 null allele.

Diana Escalante-Alcalde1, Roberto Sánchez-Sánchez, Colin L Stewart.   

Abstract

Lpp3, formerly known as Pap2b, is a lipid phosphohydrolase enzyme. Some of its substrates and products are lipids with potent biological and signaling activities such as phosphatidic acid, lysophosphatidic acid, sphingosine-1-phosphate, diacylglycerol, sphingosine, and ceramide. Lpp3 is dynamically expressed during development and is widely distributed in adult tissues. Targeted inactivation of Lpp3 gene (Ppap2b) in the mouse results in embryonic lethality because of defects in extraembryonic vascular development and gastrulation. To study the participation of Lpp3 later in development and in specific cell lineages we generated a conditional allele of Ppap2b. This was accomplished by flanking critical exons, responsible for its catalytic activity with loxP sites. A generalized Cre-mediated recombination of this allele yielded a phenotype fundamentally identical to our previously reported Ppap2b null allele.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17610274     DOI: 10.1002/dvg.20314

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  14 in total

1.  Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site.

Authors:  Andrés Nieto-Posadas; Giovanni Picazo-Juárez; Itzel Llorente; Andrés Jara-Oseguera; Sara Morales-Lázaro; Diana Escalante-Alcalde; León D Islas; Tamara Rosenbaum
Journal:  Nat Chem Biol       Date:  2011-11-20       Impact factor: 15.040

2.  Expression of LPP3 in Bergmann glia is required for proper cerebellar sphingosine-1-phosphate metabolism/signaling and development.

Authors:  Alejandro López-Juárez; Sara Morales-Lázaro; Roberto Sánchez-Sánchez; Manjula Sunkara; Hilda Lomelí; Iván Velasco; Andrew J Morris; Diana Escalante-Alcalde
Journal:  Glia       Date:  2011-01-06       Impact factor: 7.452

3.  Lipid phosphate phosphatase 3 enables efficient thymic egress.

Authors:  Béatrice Bréart; Willy D Ramos-Perez; Alejandra Mendoza; Abdelghaffar K Salous; Michael Gobert; Yong Huang; Ralf H Adams; Juan J Lafaille; Diana Escalante-Alcalde; Andrew J Morris; Susan R Schwab
Journal:  J Exp Med       Date:  2011-05-16       Impact factor: 14.307

4.  Coronary Artery Disease Risk-Associated Plpp3 Gene and Its Product Lipid Phosphate Phosphatase 3 Regulate Experimental Atherosclerosis.

Authors:  Paul A Mueller; Liping Yang; Margo Ubele; Guogen Mao; Jason Brandon; Julia Vandra; Timothy C Nichols; Diana Escalante-Alcalde; Andrew J Morris; Susan S Smyth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-19       Impact factor: 10.514

5.  Lipid-induced epigenomic changes in human macrophages identify a coronary artery disease-associated variant that regulates PPAP2B Expression through Altered C/EBP-beta binding.

Authors:  Michael E Reschen; Kyle J Gaulton; Da Lin; Elizabeth J Soilleux; Andrew J Morris; Susan S Smyth; Christopher A O'Callaghan
Journal:  PLoS Genet       Date:  2015-04-02       Impact factor: 5.917

6.  Non-cell autonomous and non-catalytic activities of ATX in the developing brain.

Authors:  Raanan Greenman; Anna Gorelik; Tamar Sapir; Jan Baumgart; Vanessa Zamor; Michal Segal-Salto; Smadar Levin-Zaidman; Vassilis Aidinis; Junken Aoki; Robert Nitsch; Johannes Vogt; Orly Reiner
Journal:  Front Neurosci       Date:  2015-03-04       Impact factor: 4.677

7.  A mouse chromosome 4 balancer ENU-mutagenesis screen isolates eleven lethal lines.

Authors:  Melissa K Boles; Bonney M Wilkinson; Andrea Maxwell; Lihua Lai; Alea A Mills; Ichiko Nishijima; Andrew P Salinger; Ivan Moskowitz; Karen K Hirschi; Bin Liu; Allan Bradley; Monica J Justice
Journal:  BMC Genet       Date:  2009-03-06       Impact factor: 2.797

8.  Lipid phosphate phosphatase 3 negatively regulates smooth muscle cell phenotypic modulation to limit intimal hyperplasia.

Authors:  Manikandan Panchatcharam; Sumitra Miriyala; Abdelghaffar Salous; Jessica Wheeler; Anping Dong; Paul Mueller; Manjula Sunkara; Diana Escalante-Alcalde; Andrew J Morris; Susan S Smyth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-10-25       Impact factor: 8.311

9.  A map of the distribution of sphingosine 1-phosphate in the spleen.

Authors:  Willy D Ramos-Perez; Victoria Fang; Diana Escalante-Alcalde; Michael Cammer; Susan R Schwab
Journal:  Nat Immunol       Date:  2015-10-26       Impact factor: 25.606

10.  Neural ablation of the PARK10 candidate Plpp3 leads to dopaminergic transmission deficits without neurodegeneration.

Authors:  Sandra Gómez-López; Ana Valeria Martínez-Silva; Teresa Montiel; Daniel Osorio-Gómez; Federico Bermúdez-Rattoni; Lourdes Massieu; Diana Escalante-Alcalde
Journal:  Sci Rep       Date:  2016-04-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.